Jardiance (Empagliflozin) is an SGLT2 inhibitor, a drug class that helps to stop sodium-glucose transport proteins that have been filtered out of the blood by the kidneys being reabsorbed back into the blood. Empagliflozin allows a significant amount of sugar to be removed through urination.
Oral diabetic medicine that helps control blood sugar levels, reduces the chances of serious complications of diabetes, and also helps prevent heart disease. Jardiance is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.